Demand for wound debridement products is surging steadily owing to steady demand from hospitals, ambulatory surgical centres, specialized clinics, and nursing facilities. While the demand from the hospital industry is to rise further, growth is likely to be complemented by sustained demand from a range of factors.
In its new report, the Future Market Insights (FMI) offers an exhaustive overview of the global wound debridement products market with focus on the key market dynamics, including drivers, trends, opportunities, restraints, and detailed information about the global advanced wound debridement products market structure. The market study presents exclusive information about how the market will grow during the forecast period of 2021 to 2031.
According to latest analysis, wound debridement product sales have witnessed a minor decline in US, the largest market globally. However, demand still continues to be strong and manufacturers can expect a steady stream of opportunities during the forecast period. US currently accounts for nearly one-fourth of all wound debridement sales globally.
The study also finds that manufacturers are focusing on launching innovative products to consolidate their market share.
“Production of pads and scalpels for effectively treating minor wounds is gaining traction. Although the profit margins in these products are low, they are sold in bulk, which remains a lucrative option for manufacturers,” says an FMI analyst.
Key Takeaways from Study
Hospitals will remain the largest demand generators for wound debridement products
Strong demand in US to continue in 2021 and beyond, making North America the largest market globally
New product innovation to be a key focus area for manufacturers
Demand for wound debridement products rising in Asia Pacific as various economies make an early recovery from COVID-19 pandemic
Applications in Treating Chronic Ulcers and Surgical Wounds Driving Demand
Demand for wound debridement products continues to remain high for treating chronic ulcers and surgical wounds. According to the study, these two application areas continue to create opportunities for market players. Of particular significant is application in chronic leg ulcers. Chronic ulceration of lower legs continues to be a challenge area, with 3.6% of people older than 65 years suffering from this (Grant Medical College).
FMI’s study reveals that use of wound debridement products in treating these types of ulcers will continue to account for steady demand over the course of the forecast period.
Demand Likely to Increase in Asia Pacific
FMI’s analysis reveals US to be the most lucrative market for wound debridement products, but owing to relatively less impact on many Asian economies, demand is likely to surge.
China, India, and South East Asian countries have been lesser impacted by the covid-19 crisis, as compared to US and Western Europe. Further, healthcare sector in these countries is going through an infrastructure revamp, which is also likely to create opportunities for manufacturers.
Manufacturers are focusing on the developing innovative wound debridement products to consolidate their positon in the market. These products are able to cure the wounds, prevent bacterial infections and accelerate the healing time. According to FMI, the key strategy being followed by the leading companies in the industry is the product portfolio expansion.
Some of the leading players in the global wound debridement market are-
Smith & Nephew PLC
Derma Sciences, Inc.
Lohmann & Rauscher International
Zimmer Biomet
DeRoyal Industries Inc.
Arobella Medical
LLC, Misonix
Söring GmbH
BSN Medical
Molnlycke Healthcare AB.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Radiation Toxicity Treatment Market: The global Radiation Toxicity Treatment Market was valued at US$ 3.55 Bn in 2021 and is expected to reach US$ 5.58 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.
Implantable Drug-Eluting Devices Market: Global Implantable Drug Eluting Devices Market is set to experience a significant growth of 6.0% CAGR from 2022 to 2029, with an estimated market value of around US$ 12.8 Bn as of 2022.
Transcutaneous Monitors Market: Global Transcutaneous Monitors Market is set to experience a significant growth of 4.3% CAGR from 2022 to 2029, with an estimated market value of around US$ 401.8 Mn as of 2022.
Demand for wound debridement products is surging steadily owing to steady demand from hospitals, ambulatory surgical centres, specialized clinics, and nursing facilities. While the demand from the hospital industry is to rise further, growth is likely to be complemented by sustained demand from a range of factors.
In its new report, the Future Market Insights (FMI) offers an exhaustive overview of the global wound debridement products market with focus on the key market dynamics, including drivers, trends, opportunities, restraints, and detailed information about the global advanced wound debridement products market structure. The market study presents exclusive information about how the market will grow during the forecast period of 2021 to 2031.
According to latest analysis, wound debridement product sales have witnessed a minor decline in US, the largest market globally. However, demand still continues to be strong and manufacturers can expect a steady stream of opportunities during the forecast period. US currently accounts for nearly one-fourth of all wound debridement sales globally.
The study also finds that manufacturers are focusing on launching innovative products to consolidate their market share.
“Production of pads and scalpels for effectively treating minor wounds is gaining traction. Although the profit margins in these products are low, they are sold in bulk, which remains a lucrative option for manufacturers,” says an FMI analyst.
Key Takeaways from Study
Hospitals will remain the largest demand generators for wound debridement products
Strong demand in US to continue in 2021 and beyond, making North America the largest market globally
New product innovation to be a key focus area for manufacturers
Demand for wound debridement products rising in Asia Pacific as various economies make an early recovery from COVID-19 pandemic
Applications in Treating Chronic Ulcers and Surgical Wounds Driving Demand
Demand for wound debridement products continues to remain high for treating chronic ulcers and surgical wounds. According to the study, these two application areas continue to create opportunities for market players. Of particular significant is application in chronic leg ulcers. Chronic ulceration of lower legs continues to be a challenge area, with 3.6% of people older than 65 years suffering from this (Grant Medical College).
FMI’s study reveals that use of wound debridement products in treating these types of ulcers will continue to account for steady demand over the course of the forecast period.
Demand Likely to Increase in Asia Pacific
FMI’s analysis reveals US to be the most lucrative market for wound debridement products, but owing to relatively less impact on many Asian economies, demand is likely to surge.
China, India, and South East Asian countries have been lesser impacted by the covid-19 crisis, as compared to US and Western Europe. Further, healthcare sector in these countries is going through an infrastructure revamp, which is also likely to create opportunities for manufacturers.
Manufacturers are focusing on the developing innovative wound debridement products to consolidate their positon in the market. These products are able to cure the wounds, prevent bacterial infections and accelerate the healing time. According to FMI, the key strategy being followed by the leading companies in the industry is the product portfolio expansion.
Some of the leading players in the global wound debridement market are-
Smith & Nephew PLC
Derma Sciences, Inc.
Lohmann & Rauscher International
Zimmer Biomet
DeRoyal Industries Inc.
Arobella Medical
LLC, Misonix
Söring GmbH
BSN Medical
Molnlycke Healthcare AB.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Radiation Toxicity Treatment Market: The global Radiation Toxicity Treatment Market was valued at US$ 3.55 Bn in 2021 and is expected to reach US$ 5.58 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.
Implantable Drug-Eluting Devices Market: Global Implantable Drug Eluting Devices Market is set to experience a significant growth of 6.0% CAGR from 2022 to 2029, with an estimated market value of around US$ 12.8 Bn as of 2022.
Transcutaneous Monitors Market: Global Transcutaneous Monitors Market is set to experience a significant growth of 4.3% CAGR from 2022 to 2029, with an estimated market value of around US$ 401.8 Mn as of 2022.